Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Trial for Primary Radiotherapy With Single-Agent Cisplatin or Combination Chemotherapy in PET/CT Defined Poor-Prognostic Cervical Cancer Patients

NCT00842660 is registered in ClinicalTrials.gov with Chang Gung Memorial Hospital as lead sponsor.

NCT NCT00842660
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00842660 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Trial for Primary Radiotherapy With Single-Agent Cisplatin or Combination Chemotherapy in PET/CT Defined Poor-Prognostic Cervical Cancer Patients
Lead sponsor
Chang Gung Memorial Hospital
Phase
Phase 3
Overall status
Unknown status
Start date
February 28, 2009
Completion date
January 31, 2013
Enrollment
172 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer